Science & Technology
Preclinical efficacy of an APOE targeted antibody for Alzheimer's disease
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41AG092063-01
Award Ceiling
$499K
Award Floor
$499K
Close Date
Aug 19, 2026
157 days leftTotal Funding
$499K
Expected Awards
1
Posted Date
Aug 20, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AG092063-01
Description
STTR Phase Phase I award: "Preclinical efficacy of an APOE targeted antibody for Alzheimer's disease" awarded to EPOCH BIOTECH, LLC in DOVER, Massachusetts. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $498,709. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.